40 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
of reimbursement from managed care plans and other third-party payors;
timing of market introduction and perceived effectiveness of competitive products … ;
obtaining pricing, reimbursement, and hospital formulary access;
establishing sales, marketing and distribution capabilities and launching commercial
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
;
the outcome of reimbursement decisions by third-party payors relating to our products;
our expectations with respect to the market opportunities …
availability of coverage and extent of reimbursement from managed care plans and other third-party payors;
timing of market introduction
S-3ASR
ZYME
Zymeworks Inc.
7 Mar 24
Automatic shelf registration
4:46pm
product candidates;
our ability to commercialize products outside of the United States;
the outcome of reimbursement decisions by third-party payors
S-3
ZYME
Zymeworks Inc.
6 Mar 24
Shelf registration
5:25pm
product candidates;
our ability to commercialize products outside of the United States;
the outcome of reimbursement decisions by third-party payors
8-K
EX-10.1
g3fj4gzbph3zs3my1zq
5 Jan 24
Departure of Directors or Certain Officers
7:00am
8-K
EX-99.1
v8j8tvvouu rwu
7 Nov 23
Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
f0gvw2e6 lw
18 May 23
Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer
8:40am
8-K
3f3rghaeijd3oq am
18 May 23
Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer
8:40am
8-K
nzgq74crqlsfzu1yzh
16 May 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
owtw4ia l7
16 May 23
Entry into a Material Definitive Agreement
8:30am
424B5
n2upur3rpyroxx7f4
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
h3q43l 9flll
8 May 23
Prospectus supplement for primary offering
5:18pm